speb/financial-data huggingface dataset:
SMRT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
SMRT balance_sheet (quarterly, 2025-09-30) — Working Capital: 128842000.00
SMRT income_statement (annual, 2025-12-31) — +Operating Expense: 88916000.00
SMRT income_statement (quarterly, 2025-12-31) — +Operating Expense: 18045000.00
SMRT income_statement (annual, 2025-12-31) — +Total Revenue: 152326000.00
SMRT income_statement (quarterly, 2025-12-31) — +Total Revenue: 36472000.00
SMRT balance_sheet (annual, 2025-12-31) — Accounts Payable: 13012000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 13012000.00
SMRT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 47401000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 47401000.00
SMRT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3685000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3685000.00
SMRT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 645051000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 645051000.00
SMRT balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2131000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2131000.00
SMRT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 24929000.00
SMRT cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
SMRT income_statement (annual, 2025-12-31) — Basic Average Shares: 189679000.00
SMRT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 189217000.00
SMRT income_statement (annual, 2025-12-31) — Basic EPS: -0.32
SMRT income_statement (quarterly, 2025-12-31) — Basic EPS: -0.02
SMRT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 142482000.00
SMRT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 100022000.00
SMRT balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 950000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 950000.00
SMRT cash_flow (annual, 2025-12-31) — Capital Expenditure: -8625000.00
SMRT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1684000.00
SMRT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -5072000.00
SMRT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -1683000.00
SMRT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 5792000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 5792000.00
SMRT balance_sheet (annual, 2025-12-31) — Capital Stock: 19000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 19000.00
SMRT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 104550000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 104550000.00
SMRT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 104550000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 104550000.00
SMRT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -7444000.00
SMRT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -448000.00
SMRT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -8625000.00
SMRT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1684000.00
SMRT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -21575000.00
SMRT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 7657000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Account Payable: 4190000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2240000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -11289000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -10158000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Inventory: 4496000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Inventory: 1106000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -592000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -290000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -23122000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -1282000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Payable: 4190000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Payable: 2240000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -7099000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -7918000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 6568000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 11185000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Receivables: 12915000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 5054000.00
SMRT cash_flow (annual, 2025-12-31) — Change In Working Capital: -6834000.00
SMRT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 7855000.00
SMRT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 12915000.00
SMRT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 5054000.00
SMRT cash_flow (annual, 2025-12-31) — Changes In Cash: -37644000.00
SMRT cash_flow (quarterly, 2025-12-31) — Changes In Cash: 5525000.00
SMRT balance_sheet (annual, 2025-12-31) — Common Stock: 19000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Common Stock: 19000.00
SMRT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 232139000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 232139000.00
SMRT cash_flow (annual, 2025-12-31) — Common Stock Payments: -4889000.00
SMRT cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 29000.00
SMRT income_statement (annual, 2025-12-31) — Cost Of Revenue: 102457000.00
SMRT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 22402000.00
SMRT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 3383000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 3383000.00
SMRT balance_sheet (annual, 2025-12-31) — Current Assets: 187878000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Current Assets: 187878000.00
SMRT balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 3068000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 3068000.00
SMRT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 32966000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 32966000.00
SMRT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 32966000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 32966000.00
SMRT balance_sheet (annual, 2025-12-31) — Current Liabilities: 60018000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 60018000.00
SMRT balance_sheet (annual, 2025-12-31) — Current Provisions: 423000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Current Provisions: 423000.00
SMRT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 8430000.00
SMRT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2220000.00
SMRT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 8430000.00
SMRT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2220000.00
SMRT income_statement (annual, 2025-12-31) — Diluted Average Shares: 189679000.00
SMRT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 189217000.00
SMRT income_statement (annual, 2025-12-31) — Diluted EPS: -0.32
SMRT income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.02
SMRT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -60558000.00
SMRT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3244000.00
SMRT income_statement (annual, 2025-12-31) — EBIT: -60139000.00
SMRT income_statement (quarterly, 2025-12-31) — EBIT: -25067000.00
SMRT income_statement (annual, 2025-12-31) — EBITDA: -51709000.00
SMRT income_statement (quarterly, 2025-12-31) — EBITDA: -22847000.00
SMRT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -288000.00
SMRT cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -997000.00
SMRT cash_flow (annual, 2025-12-31) — End Cash Position: 104550000.00
SMRT cash_flow (quarterly, 2025-12-31) — End Cash Position: 104550000.00
SMRT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -7444000.00
SMRT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -448000.00
SMRT balance_sheet (annual, 2025-12-31) — Finished Goods: 26359000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Finished Goods: 26359000.00
SMRT cash_flow (annual, 2025-12-31) — Free Cash Flow: -30200000.00
SMRT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 5973000.00
SMRT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 363000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 363000.00
SMRT income_statement (annual, 2025-12-31) — General And Administrative Expense: 43241000.00
SMRT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 8741000.00
SMRT balance_sheet (annual, 2025-12-31) — Goodwill: 92339000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Goodwill: 92339000.00
SMRT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 122686000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 122686000.00
SMRT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 49532000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 49532000.00
SMRT balance_sheet (annual, 2025-12-31) — Gross PPE: 11616000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 11616000.00
SMRT income_statement (annual, 2025-12-31) — Gross Profit: 49869000.00
SMRT income_statement (quarterly, 2025-12-31) — Gross Profit: 14070000.00
SMRT income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 24929000.00
SMRT income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
SMRT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 402000.00
SMRT cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 62000.00
SMRT income_statement (annual, 2025-12-31) — Interest Expense: 378000.00
SMRT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 378000.00
SMRT income_statement (annual, 2025-12-31) — Interest Income: 4299000.00
SMRT income_statement (quarterly, 2025-12-31) — Interest Income: 1196000.00
SMRT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 4299000.00
SMRT income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1196000.00
SMRT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 203000.00
SMRT cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 75000.00
SMRT balance_sheet (annual, 2025-12-31) — Inventory: 26670000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Inventory: 26670000.00
SMRT balance_sheet (annual, 2025-12-31) — Invested Capital: 232139000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 232139000.00
SMRT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -8625000.00
SMRT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1684000.00
SMRT balance_sheet (annual, 2025-12-31) — Leases: 5202000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Leases: 5202000.00
SMRT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 5792000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 5792000.00
SMRT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5792000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5792000.00
SMRT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2654000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2654000.00
SMRT cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
SMRT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -4889000.00
SMRT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 29000.00
SMRT income_statement (annual, 2025-12-31) — Net Income: -60558000.00
SMRT income_statement (quarterly, 2025-12-31) — Net Income: -3244000.00
SMRT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -60558000.00
SMRT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3244000.00
SMRT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -60558000.00
SMRT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3244000.00
SMRT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -60558000.00
SMRT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3244000.00
SMRT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -60558000.00
SMRT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3244000.00
SMRT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -60558000.00
SMRT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3244000.00
SMRT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -60558000.00
SMRT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3244000.00
SMRT income_statement (annual, 2025-12-31) — Net Interest Income: 3921000.00
SMRT income_statement (quarterly, 2025-12-31) — Net Interest Income: 818000.00
SMRT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3921000.00
SMRT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 818000.00
SMRT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2840000.00
SMRT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -477000.00
SMRT balance_sheet (annual, 2025-12-31) — Net PPE: 7931000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Net PPE: 7931000.00
SMRT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -3553000.00
SMRT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1000.00
SMRT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 109453000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 109453000.00
SMRT balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 121000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 121000.00
SMRT balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 22968000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 22968000.00
SMRT balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 22968000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 22968000.00
SMRT income_statement (annual, 2025-12-31) — Normalized EBITDA: -26780000.00
SMRT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -22847000.00
SMRT income_statement (annual, 2025-12-31) — Normalized Income: -40864090.00
SMRT income_statement (quarterly, 2025-12-31) — Normalized Income: -3244000.00
SMRT cash_flow (annual, 2025-12-31) — Operating Cash Flow: -21575000.00
SMRT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 7657000.00
SMRT income_statement (annual, 2025-12-31) — Operating Income: -39047000.00
SMRT income_statement (quarterly, 2025-12-31) — Operating Income: -3975000.00
SMRT income_statement (annual, 2025-12-31) — Operating Revenue: 152326000.00
SMRT income_statement (quarterly, 2025-12-31) — Operating Revenue: 36472000.00
SMRT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 189677000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 189677000.00
SMRT balance_sheet (annual, 2025-12-31) — Other Current Assets: 333000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 333000.00
SMRT balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 2456000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 2456000.00
SMRT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 363000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 363000.00
SMRT income_statement (annual, 2025-12-31) — Other Gand A: 43241000.00
SMRT income_statement (quarterly, 2025-12-31) — Other Gand A: 8741000.00
SMRT income_statement (annual, 2025-12-31) — Other Income Expense: -25391000.00
SMRT income_statement (quarterly, 2025-12-31) — Other Income Expense: -177000.00
SMRT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 30347000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 30347000.00
SMRT cash_flow (annual, 2025-12-31) — Other Non Cash Items: 843000.00
SMRT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 434000.00
SMRT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2309000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2309000.00
SMRT balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 8000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 8000.00
SMRT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -462000.00
SMRT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -177000.00
SMRT balance_sheet (annual, 2025-12-31) — Other Properties: 2810000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Other Properties: 2810000.00
SMRT balance_sheet (annual, 2025-12-31) — Payables: 13012000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Payables: 13012000.00
SMRT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 16395000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 16395000.00
SMRT balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7778000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7778000.00
SMRT balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 0.00
SMRT balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 0.00
SMRT balance_sheet (annual, 2025-12-31) — Prepaid Assets: 5856000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 5856000.00
SMRT income_statement (annual, 2025-12-31) — Pretax Income: -60517000.00
SMRT income_statement (quarterly, 2025-12-31) — Pretax Income: -3334000.00
SMRT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 285000.00
SMRT cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
SMRT balance_sheet (annual, 2025-12-31) — Properties: 0.00
SMRT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SMRT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 2836000.00
SMRT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -1306000.00
SMRT cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
SMRT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -3553000.00
SMRT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1000.00
SMRT balance_sheet (annual, 2025-12-31) — Raw Materials: 311000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Raw Materials: 311000.00
SMRT balance_sheet (annual, 2025-12-31) — Receivables: 47401000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Receivables: 47401000.00
SMRT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 102457000.00
SMRT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 22402000.00
SMRT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 8430000.00
SMRT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2220000.00
SMRT cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -4889000.00
SMRT cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 29000.00
SMRT income_statement (annual, 2025-12-31) — Research And Development: 26224000.00
SMRT income_statement (quarterly, 2025-12-31) — Research And Development: 5352000.00
SMRT balance_sheet (annual, 2025-12-31) — Retained Earnings: -413294000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -413294000.00
SMRT income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 19451000.00
SMRT income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 3952000.00
SMRT income_statement (annual, 2025-12-31) — Selling General And Administration: 62692000.00
SMRT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 12693000.00
SMRT balance_sheet (annual, 2025-12-31) — Share Issued: 189677000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Share Issued: 189677000.00
SMRT income_statement (annual, 2025-12-31) — Special Income Charges: -24929000.00
SMRT income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
SMRT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 8779000.00
SMRT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1698000.00
SMRT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 232139000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 232139000.00
SMRT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 109453000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 109453000.00
SMRT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -5235090.00
SMRT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SMRT income_statement (annual, 2025-12-31) — Tax Provision: 41000.00
SMRT income_statement (quarterly, 2025-12-31) — Tax Provision: -90000.00
SMRT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
SMRT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.03
SMRT balance_sheet (annual, 2025-12-31) — Total Assets: 320925000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Total Assets: 320925000.00
SMRT balance_sheet (annual, 2025-12-31) — Total Capitalization: 232139000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 232139000.00
SMRT balance_sheet (annual, 2025-12-31) — Total Debt: 5792000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Total Debt: 5792000.00
SMRT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 232139000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 232139000.00
SMRT income_statement (annual, 2025-12-31) — Total Expenses: 191373000.00
SMRT income_statement (quarterly, 2025-12-31) — Total Expenses: 40447000.00
SMRT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 88786000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 88786000.00
SMRT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 133047000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 133047000.00
SMRT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 28768000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 28768000.00
SMRT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -63976000.00
SMRT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -3975000.00
SMRT income_statement (annual, 2025-12-31) — Total Unusual Items: -24929000.00
SMRT income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
SMRT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -24929000.00
SMRT income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SMRT balance_sheet (annual, 2025-12-31) — Working Capital: 127860000.00
SMRT balance_sheet (quarterly, 2025-12-31) — Working Capital: 127860000.00
SMRT income_statement (quarterly, 2026-03-31) — +Operating Expense: 20215000.00
SMRT income_statement (quarterly, 2026-03-31) — +Total Revenue: 38683000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8550000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 36753000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3953000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 648501000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1935000.00
SMRT cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
SMRT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 191654000.00
SMRT income_statement (quarterly, 2026-03-31) — Basic EPS: -0.02
SMRT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 104550000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 938000.00
SMRT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1088000.00
SMRT cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -1058000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 5470000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 19000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 98821000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 98821000.00
SMRT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 393000.00
SMRT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1088000.00
SMRT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4543000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -4452000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -4473000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Inventory: 2499000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -299000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -8361000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Payable: -4452000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -8925000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -559000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Receivables: 10754000.00
SMRT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -4891000.00
SMRT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 10754000.00
SMRT cash_flow (quarterly, 2026-03-31) — Changes In Cash: -5238000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Common Stock: 19000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 230674000.00
SMRT cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
SMRT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 23562000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 3369000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Current Assets: 168574000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 1861000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 24920000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 24920000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 42719000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Current Provisions: 240000.00
SMRT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2223000.00
SMRT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2223000.00
SMRT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 191654000.00
SMRT income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.02
SMRT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -4448000.00
SMRT income_statement (quarterly, 2026-03-31) — EBIT: -4309000.00
SMRT income_statement (quarterly, 2026-03-31) — EBITDA: -2086000.00
SMRT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -491000.00
SMRT cash_flow (quarterly, 2026-03-31) — End Cash Position: 98821000.00
SMRT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 393000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Finished Goods: 24086000.00
SMRT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -5631000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -104000.00
SMRT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 9623000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Goodwill: 92339000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 121855000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 38688000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 11512000.00
SMRT income_statement (quarterly, 2026-03-31) — Gross Profit: 15121000.00
SMRT cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 39000.00
SMRT income_statement (quarterly, 2026-03-31) — Interest Expense: 99000.00
SMRT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 99000.00
SMRT income_statement (quarterly, 2026-03-31) — Interest Income: 860000.00
SMRT income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 860000.00
SMRT cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 72000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Inventory: 24397000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 230674000.00
SMRT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1088000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Leases: 5216000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5470000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5470000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2660000.00
SMRT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
SMRT income_statement (quarterly, 2026-03-31) — Net Income: -4448000.00
SMRT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4448000.00
SMRT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4448000.00
SMRT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4448000.00
SMRT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4448000.00
SMRT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4448000.00
SMRT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4448000.00
SMRT income_statement (quarterly, 2026-03-31) — Net Interest Income: 761000.00
SMRT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 761000.00
SMRT cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -559000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Net PPE: 7559000.00
SMRT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -30000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 108819000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 46000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 21368000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 21368000.00
SMRT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2086000.00
SMRT income_statement (quarterly, 2026-03-31) — Normalized Income: -4448000.00
SMRT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4543000.00
SMRT income_statement (quarterly, 2026-03-31) — Operating Income: -5094000.00
SMRT income_statement (quarterly, 2026-03-31) — Operating Revenue: 38683000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 192721000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 327000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1963000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -104000.00
SMRT income_statement (quarterly, 2026-03-31) — Other Gand A: 9623000.00
SMRT income_statement (quarterly, 2026-03-31) — Other Income Expense: -75000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 29516000.00
SMRT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 145000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2202000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 5000.00
SMRT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -75000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Other Properties: 2698000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Payables: 8550000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 11919000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3677000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 0.00
SMRT balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 6415000.00
SMRT income_statement (quarterly, 2026-03-31) — Pretax Income: -4408000.00
SMRT cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 952000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
SMRT cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -629000.00
SMRT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -30000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Raw Materials: 311000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Receivables: 36753000.00
SMRT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 23562000.00
SMRT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2223000.00
SMRT cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
SMRT income_statement (quarterly, 2026-03-31) — Research And Development: 6146000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -417742000.00
SMRT income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 4446000.00
SMRT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 14069000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Share Issued: 192721000.00
SMRT income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
SMRT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3057000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 230674000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 108819000.00
SMRT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SMRT income_statement (quarterly, 2026-03-31) — Tax Provision: 40000.00
SMRT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
SMRT balance_sheet (quarterly, 2026-03-31) — Total Assets: 300236000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 230674000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Total Debt: 5470000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 230674000.00
SMRT income_statement (quarterly, 2026-03-31) — Total Expenses: 43777000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 69562000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 131662000.00
SMRT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 26843000.00
SMRT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -5094000.00
SMRT income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
SMRT income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SMRT balance_sheet (quarterly, 2026-03-31) — Working Capital: 125855000.00
SMRT income_statement (quarterly, 2026-03-31) — Write Off: 0.00
SMRV.V income_statement (annual, 2021-12-31) — Basic Average Shares: 12178250.00
SMRV.V income_statement (annual, 2021-12-31) — Basic EPS: -0.02
SMRV.V cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: 296714.00
SMRV.V cash_flow (annual, 2021-12-31) — Common Stock Issuance: 296714.00
SMRV.V income_statement (annual, 2021-12-31) — Diluted Average Shares: 12178250.00
SMRV.V income_statement (annual, 2021-12-31) — Diluted EPS: -0.02
SMRV.V cash_flow (annual, 2021-12-31) — Financing Cash Flow: 296714.00
SMRV.V cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 296714.00
SMRV.V cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 296714.00
SMRV.V cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -499746.00
SMRV.V balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: 4723052.00
SMRV.V balance_sheet (annual, 2021-12-31) — Other Equity Interest: 4723052.00
SMRV.V cash_flow (annual, 2021-12-31) — Purchase Of PPE: -499746.00
SMRV.V income_statement (annual, 2021-12-31) — Salaries And Wages: 0.00
SMRV.V cash_flow (annual, 2021-12-31) — Stock Based Compensation: 0.00
SMRV.V income_statement (annual, 2022-12-31) — +Operating Expense: 514071.00
SMRV.V income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
SMRV.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 44251.00
SMRV.V cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 392021.00
SMRV.V income_statement (annual, 2022-12-31) — Basic Average Shares: 12337397.00
SMRV.V income_statement (annual, 2022-12-31) — Basic EPS: -0.08
SMRV.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 595542.00
SMRV.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -243732.00
SMRV.V balance_sheet (annual, 2022-12-31) — Capital Stock: 22102042.00
SMRV.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 661705.00
SMRV.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 661705.00
SMRV.V balance_sheet (annual, 2022-12-31) — Cash Financial: 661705.00
SMRV.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
SMRV.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 200349.00
SMRV.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -134186.00
SMRV.V cash_flow (annual, 2022-12-31) — Change In Account Payable: 27388.00
SMRV.V cash_flow (annual, 2022-12-31) — Change In Payable: 249358.00
SMRV.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 249358.00
SMRV.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -4521.00
SMRV.V cash_flow (annual, 2022-12-31) — Change In Receivables: -1771.00
SMRV.V cash_flow (annual, 2022-12-31) — Change In Working Capital: 243066.00
SMRV.V cash_flow (annual, 2022-12-31) — Changes In Cash: 66163.00
SMRV.V balance_sheet (annual, 2022-12-31) — Common Stock: 22102042.00
SMRV.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1363274.00
SMRV.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
SMRV.V balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 130500.00
SMRV.V balance_sheet (annual, 2022-12-31) — Current Assets: 700800.00
SMRV.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 621816.00
SMRV.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 12337397.00
SMRV.V income_statement (annual, 2022-12-31) — Diluted EPS: -0.08
SMRV.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -888963.00
SMRV.V balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 447065.00
SMRV.V income_statement (annual, 2022-12-31) — EBIT: -514071.00
SMRV.V income_statement (annual, 2022-12-31) — EBITDA: -514071.00
SMRV.V cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
SMRV.V cash_flow (annual, 2022-12-31) — End Cash Position: 661705.00
SMRV.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
SMRV.V cash_flow (annual, 2022-12-31) — Free Cash Flow: -377918.00
SMRV.V income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 17129.00
SMRV.V balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 4845529.00
SMRV.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 311832.00
SMRV.V income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 392021.00
SMRV.V balance_sheet (annual, 2022-12-31) — Invested Capital: 1363274.00
SMRV.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: 200349.00
SMRV.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
SMRV.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
SMRV.V cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -2787.00
SMRV.V income_statement (annual, 2022-12-31) — Net Income: -888963.00
SMRV.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -888963.00
SMRV.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -888963.00
SMRV.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -888963.00
SMRV.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -888963.00
SMRV.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -888963.00
SMRV.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -888963.00
SMRV.V cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 444081.00
SMRV.V balance_sheet (annual, 2022-12-31) — Net PPE: 1284290.00
SMRV.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -243732.00
SMRV.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1363274.00
SMRV.V income_statement (annual, 2022-12-31) — Normalized EBITDA: -139179.00
SMRV.V income_statement (annual, 2022-12-31) — Normalized Income: -514071.00
SMRV.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: -134186.00
SMRV.V cash_flow (annual, 2022-12-31) — Operating Gains Losses: -2787.00
SMRV.V income_statement (annual, 2022-12-31) — Operating Income: -514071.00
SMRV.V income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
SMRV.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 12337397.00
SMRV.V balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 4845529.00
SMRV.V balance_sheet (annual, 2022-12-31) — Other Equity Interest: 4845529.00
SMRV.V income_statement (annual, 2022-12-31) — Other Gand A: 189355.00
SMRV.V income_statement (annual, 2022-12-31) — Other Income Expense: -374892.00
SMRV.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: 122477.00
SMRV.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 201602.00
SMRV.V balance_sheet (annual, 2022-12-31) — Payables: 491316.00
SMRV.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 621816.00
SMRV.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 31769.00
SMRV.V income_statement (annual, 2022-12-31) — Pretax Income: -888963.00
SMRV.V balance_sheet (annual, 2022-12-31) — Receivables: 7326.00
SMRV.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -25584297.00
SMRV.V income_statement (annual, 2022-12-31) — Salaries And Wages: 122477.00
SMRV.V income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 637.00
SMRV.V income_statement (annual, 2022-12-31) — Selling General And Administration: 312469.00
SMRV.V balance_sheet (annual, 2022-12-31) — Share Issued: 12337397.00
SMRV.V income_statement (annual, 2022-12-31) — Special Income Charges: -392021.00
SMRV.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1363274.00
SMRV.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1363274.00
SMRV.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
SMRV.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
SMRV.V balance_sheet (annual, 2022-12-31) — Taxes Receivable: 7326.00
SMRV.V balance_sheet (annual, 2022-12-31) — Total Assets: 1985090.00
SMRV.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 1363274.00
SMRV.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1363274.00
SMRV.V income_statement (annual, 2022-12-31) — Total Expenses: 514071.00
SMRV.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 621816.00
SMRV.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1284290.00
SMRV.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
SMRV.V income_statement (annual, 2022-12-31) — Total Unusual Items: -374892.00
SMRV.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -374892.00
SMRV.V balance_sheet (annual, 2022-12-31) — Working Capital: 78984.00
SMRV.V income_statement (annual, 2023-12-31) — +Operating Expense: 500842.00
SMRV.V income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
SMRV.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 44335.00
SMRV.V cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
SMRV.V income_statement (annual, 2023-12-31) — Basic Average Shares: 12337397.00
SMRV.V income_statement (annual, 2023-12-31) — Basic EPS: -0.04
SMRV.V cash_flow (annual, 2023-12-31) — Beginning Cash Position: 661705.00
SMRV.V cash_flow (annual, 2023-12-31) — Capital Expenditure: -107041.00
SMRV.V balance_sheet (annual, 2023-12-31) — Capital Stock: 22102042.00
SMRV.V balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 458372.00
SMRV.V balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 458372.00
SMRV.V balance_sheet (annual, 2023-12-31) — Cash Financial: 458372.00
SMRV.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -107041.00
SMRV.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -85630.00
SMRV.V cash_flow (annual, 2023-12-31) — Change In Account Payable: 62559.00
SMRV.V cash_flow (annual, 2023-12-31) — Change In Payable: 314152.00
SMRV.V cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 314152.00
SMRV.V cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -604.00
SMRV.V cash_flow (annual, 2023-12-31) — Change In Receivables: 6910.00
SMRV.V cash_flow (annual, 2023-12-31) — Change In Working Capital: 320458.00
SMRV.V cash_flow (annual, 2023-12-31) — Changes In Cash: -192671.00
SMRV.V balance_sheet (annual, 2023-12-31) — Common Stock: 22102042.00
SMRV.V balance_sheet (annual, 2023-12-31) — Common Stock Equity: 954310.00
SMRV.V balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 193000.00
SMRV.V balance_sheet (annual, 2023-12-31) — Current Assets: 490433.00
SMRV.V balance_sheet (annual, 2023-12-31) — Current Liabilities: 927454.00
SMRV.V income_statement (annual, 2023-12-31) — Diluted Average Shares: 12337397.00
SMRV.V income_statement (annual, 2023-12-31) — Diluted EPS: -0.04
SMRV.V income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -501137.00
SMRV.V balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 690119.00
SMRV.V income_statement (annual, 2023-12-31) — EBIT: -500842.00
SMRV.V income_statement (annual, 2023-12-31) — EBITDA: -500842.00
SMRV.V cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -10662.00
SMRV.V cash_flow (annual, 2023-12-31) — End Cash Position: 458372.00
SMRV.V cash_flow (annual, 2023-12-31) — Free Cash Flow: -192671.00
SMRV.V income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -295.00
SMRV.V balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 4937702.00
SMRV.V income_statement (annual, 2023-12-31) — General And Administrative Expense: 298540.00
SMRV.V income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
SMRV.V balance_sheet (annual, 2023-12-31) — Invested Capital: 954310.00
SMRV.V cash_flow (annual, 2023-12-31) — Investing Cash Flow: -107041.00
SMRV.V cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 2876.00
SMRV.V income_statement (annual, 2023-12-31) — Net Income: -501137.00
SMRV.V income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -501137.00
SMRV.V income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -501137.00
SMRV.V income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -501137.00